Riders · Board of Pharmacy · Article VIII: Regulatory

Appropriation of Official Prescription Form Fees

Rider 3 in the 2026-27 Act, page VIII-44

Through the session

  1. 2024-25 Act In current law rider 4
  2. Introduced (Senate) Amended rider 3
  3. Introduced (House) Amended rider 3
  4. Senate substitute Amended rider 3
  5. House substitute Unchanged rider 3
  6. House passed Unchanged rider 3
  7. Conference Unchanged rider 3
  8. 2026-27 Act Unchanged rider 3

Pick any two steps to compare their wording.

What changed in the text

Introduced (Senate) → Senate substitute: 202 6 became 2026; 202 7 became 2027; 202 6 became 2026; 202 6 became 2026.

Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 202 6 2026 and $200,000 in fiscal year 202 7 2027 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 202 6, 2026, are appropriated in the fiscal year beginning September 1, 202 6, 2026, for the same purpose.

Removed words are struck through; added words are underlined. Sources: Introduced (Senate) · Senate substitute.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 4 First version — Page VIII-39
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) 3 was 4 Amended — Page VIII-42
Introduced (House)House Bill 1 as introduced (LBB recommended, House) 3 was 4 Amended — Page VIII-42
Senate substituteCommittee Substitute for Senate Bill 1 3 Amended Updated years only Page VIII-39
House substituteHouse Committee Substitute for Senate Bill 1 3 Unchanged Updated years only Page VIII-39
House passedSenate Bill 1 as passed the second house 3 Unchanged Updated years only Page VIII-39
ConferenceConference Committee Report for Senate Bill 1 3 Unchanged Updated years only Page VIII-44
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 3 Unchanged Updated years only Page VIII-44
Full text of each wording

Senate substitute, House substitute, House passed, Conference, 2026-27 Act

Source, page VIII-44

Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2026 and $200,000 in fiscal year 2027 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 2026, are appropriated in the fiscal year beginning September 1, 2026, for the same purpose.

Introduced (House)

Source, page VIII-42

Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2026 and $200,000 in fiscal year 202 7 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 202 6, are appropriated in the fiscal year beginning September 1, 202 6, for the same purpose.

Introduced (Senate)

Source, page VIII-42

Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 202 6 and $200,000 in fiscal year 202 7 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code, Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 202 6, are appropriated in the fiscal year beginning September 1, 202 6, for the same purpose.

2024-25 Act

Source, page VIII-39

Appropriation of Official Prescription Form Fees. Out of the amounts appropriated above to the Board of Pharmacy from Appropriated Receipts in Strategy B.1.3, Prescription Monitoring Program, the amounts of $200,000 in fiscal year 2024 and $200,000 in fiscal year 2025 are for the production, printing, and sale of official prescription forms pursuant to Health and Safety Code Section 481.075 from fees collected from the sale of official prescription forms. In addition to amounts appropriated above in Strategy B.1.3, Prescription Monitoring Program, any additional fees collected from the sale of official prescription forms for the production, printing, and sale of official prescription forms are appropriated for the same purpose. Any unobligated or unexpended balances of these funds remaining as of August 31, 2024, are appropriated in the fiscal year beginning September 1, 2024, for the same purpose.